| [1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| [2] |
Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(10):589-604.
|
| [3] |
Pascual S, Herrera I, Irurzun J. New advances in hepatocellular carcinoma[J]. World J Hepatol, 2016, 8(9):421-438.
|
| [4] |
Dehkhoda F, Lee CMM, Medina J, et al. The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects[J]. Front Endocrinol, 2018(9):35.
|
| [5] |
Bergan-Roller HE, Sheridan MA. The growth hormone signaling system: insights into coordinating the anabolic and catabolic actions of growth hormone[J]. Gen Comp Endocrinol, 2018(258):119-133.
|
| [6] |
Perry JK, Emerald BS, Mertani HC, et al. The oncogenic potential of growth hormone[J]. Growth Horm IGF Res, 2006, 16(5/6):277-289.
|
| [7] |
Wu ZS, Yang K, Wan Y, et al. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma[J]. J Clin Endocrinol Metab, 2011, 96(10):E1619-1629.
|
| [8] |
Chesnokova V, Zonis S, Zhou C, et al. Growth hormone is permissive for neoplastic colon growth[J]. Proc Natl Acad Sci U S A, 2016, 113(23):E3250-3259.
|
| [9] |
Lango Allen H, Estrada K, Lettre G, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height[J]. Nature, 2010, 467(7317):832-838.
|
| [10] |
Cheng M, Huang W, Cai W, et al. Growth hormone receptor promotes osteosarcoma cell growth and metastases[J]. FEBS Open Bio, 2020, 10(1):127-134.
|
| [11] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
| [12] |
Guevara-Aguirre J, Guevara A, Palacios I, et al. GH and GHR signaling in human disease[J]. Growth Horm IGF Res, 2018(38):34-38.
|
| [13] |
Chhabra Y, Waters MJ, Brooks AJ. Role of the growth hormone-IGF-1 axis in cancer[J]. Expert Rev Endocrinol Metab, 2011, 6(1): 71-84.
|
| [14] |
Brunet-Dunand SE, Vouyovitch C, Araneda S, et al. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma[J]. Endocrinology, 2009, 150(3):1341-1352.
|
| [15] |
Basu R, Wu S, Kopchick JJ. Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways[J]. Oncotarget, 2017, 8(13):21579-21598.
|
| [16] |
Conway-Campbell BL, Wooh JW, Brooks AJ, et al. Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis[J]. Proc Natl Acad Sci U S A, 2007, 104(33):13331-13336.
|
| [17] |
Niimi S, Hayakawa T, Tanaka A. Hormonal regulation of growth hormone receptors in primary cultured rat hepatocytes[J]. Endocrinology, 1990, 127(2):688-694.
|
| [18] |
Katz TA, Grimm SL, Kaushal A, et al. Hepatic tumor formation in adult mice developmentally exposed to organotin[J]. Environ Health Perspect, 2020, 128(1):17010.
|
| [19] |
Cao J, Luo SM, Liang L, et al. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis[J]. JPEN J Parenter Enteral Nutr, 2007, 31(6):496-501.
|
| [20] |
Berman RS, Harrison LE, Pearlstone DB, et al. Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery[J]. Ann Surg, 1999, 229(1):1-10.
|
| [21] |
Luo SM, Liang LJ, Lai JM. Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis[J]. World J Gastroenterol, 2004, 10(9):1292-1296.
|